Lowering LDL cholesterol in clinical practice: time for change?

Abushamat, Layla A; Ballantyne, Christie M

Abushamat, Layla A; Ballantyne, Christie M.

Affiliation

Abushamat LA; Baylor College of Medicine, Houston, TX 77030, USA.
Ballantyne CM; Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: cmb@bcm.edu.

Lancet ; 400(10349): 341-343, 2022 07 30.

Article in En | MEDLINE | ID: mdl-35863368

Subject(s)

Anticholesteremic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Anticholesteremic Agents/therapeutic use; Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Hypercholesterolemia/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypercholesterolemia / Anticholesteremic Agents Limits: Humans Language: En Journal: Lancet Year: 2022 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google